PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook

by Newsfeed



Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.


Sandusky, OH, January 14, 2021 – OTC PR WIRE PAO Group, Inc. (OTC PINK: PAOG) today published a management outlook for 2021 on the company’s strategy to develop and monetize the cannabis assets acquired last year.  The strategic outlook is included in its entirety below:

PAOG 2021 Cannabis Biopharmaceutical Strategic Outlook

PAOG is a longtime participant in the cannabis sector working on initiatives to introduce cannabis treatments as alternatives to traditional pharmaceuticals, particularly where existing pharmaceutical treatments have potentially severe secondary ramifications as is the case with opioid based treatments.

Last year, the company shifted its primary focus…



Read Full Article Here